Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Pedro Beltran

At a glance: Pedro Beltran is CEO, President at BridgeBio Oncology Therapeutics (BBOT). Their latest SEC Form 4, filed Nov 20, 2026, reported a sale of $3K. On file: 0 purchase lines ($0) and 1 sale line ($3K).

Disclosed holdings: about $76K of BBOT stock: 41,659 shares reported on their latest Form 4 (filed Nov 20, 2026), valued at the Nov 20, 2026 close of $1.82. This counts only BBOT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CEO, President at BridgeBio Oncology Therapeutics, Inc. (BBOT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3K

Reported trades

Filed Stock Type Shares Price Value Since
Nov 20 NewSEC BBOTBridgeBio Oncology Therapeutics, Inc. Sell Plan 1,87041,659 held (−4%) $1.84 $3K -1.2%
  • Sell

    CEO, President Pedro Beltran sold $3K of BBOT at $1.84 — pre-scheduled 10b5-1 plan sale.

Follow Pedro Beltran

Get one email when Pedro Beltran files a new purchase or sale. Free.

At most one email a day about Pedro Beltran, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.